Clinical Trial Update: Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women [Phase 4]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 4 double-blind, placebo-controlled study evaluating raloxifene for negative symptoms of schizophrenia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Raloxifene (raloxifene)

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED